Tirzepatide

Tirzepatide Research Compound (40 mg) is a synthetic polypeptide reagent designed for the evaluation of dual-pathway signaling in GIP and GLP-1 receptor models. It is provided in a stable, lyophilized format suitable for mass spectrometry calibration and cell-free binding studies.